FDA Approves New Gilead Daily HIV Pill Designed to Streamline Regimens for Suppressed Patients
The FDA has approved a new daily HIV tablet from Gilead Sciences designed for virologically suppressed patients looking to switch from existing single-tablet regimens, offering…